Polypeptides against IL-23
US10968271B2 · kind B2 · utility
8Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 28, 2016 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Oct 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/569
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to amino acid sequences that are directed against Interleukin-23 (IL-23). The amino acid sequences of the present invention comprise two NANOBODIES® against IL-23 and one NANOBODY® against serum albumin, linked by two linkers (9GS linkers). In particular, the invention relates to the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 3 (listed in Table 1 and FIG. 1) (also referred to herein as “anti-IL 23 polypeptides of the invention”).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.